Small Pharma to Participate in Upcoming September Investor
LONDON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company...
Source: globenewswire.com
📰 Eric Ribner News
Page 4 - Eric Ribner News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Ribner. Real-time updates on events, politics, business and more.
Enlivex Receives Notice of Allowance for Japanese Patent Application Covering Allocetra Derived from Pooled Donor Cells
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Eric Ribner Oren Hershkovitz Shachar Shlosberger Exchange Commission Enlivex Therapeutics Ltd Japanese Patent Office
Source: apnews.com
Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious...
Source: prnewswire.com
Canadian Patent Grant Strengthens Small Pharma's International Position
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
U.S. Patent Grant to Strengthen Small Pharma's DMT Patent Strategy With Injectable Formulation
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious...
Source: prnewswire.com
Eyenovia Provides Manufacturing Update and Announces
New internal manufacturing capabilities to complement existing contract manufacturing relationships...
Source: globenewswire.com
Eyenovia Announces Appointments of Dr. Ellen Strahlman and
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of...
Source: globenewswire.com
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
SAN JOSE, Calif., June 21, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preve...
Source: businessinsider.com
Todos Medical Completes Validation of 27 Pathogen UTI PCR Panel at Its CLIA/CAP Laboratory Provista Diagnostics
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com